Vaccines

14 Oct 2009 Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Proof of Concept Study
08 Oct 2009 Bayer Schering Pharma collaborates with AC Immune in the field of Alzheimer´s disease
08 Oct 2009 Panenza®* and Humenza®* Influenza A(H1N1) Vaccines Demonstrate Robust Immune Response After One Dose
07 Oct 2009 Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
07 Oct 2009 Vical's TransVax(TM) CMV Vaccine Elicits Long-Term Immune Responses in Phase 2 Trial
05 Oct 2009 Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial
05 Oct 2009 Inovio Biomedical Demonstrates Protective Immune Responses Against Novel H1N1 (2009) Influenza Virus in Ferret Model
02 Oct 2009 Baxter Receives EMEA Positive Opinion for CELVAPAN H1N1 Pandemic Influenza Vaccine
01 Oct 2009 Sanofi Pasteur Announces Results of U.S. Clinical Trials in Adults Following One Dose of Influenza A (H1N1) Vaccine
01 Oct 2009 Medicago begins human clinical testing with its avian flu pandemic vaccine
01 Oct 2009 Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection
29 Sep 2009 Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine
25 Sep 2009 Novartis A(H1N1) Pandemic Influenza vaccine Focetria® receives positive opinion from CHMP
25 Sep 2009 Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators
25 Sep 2009 Wyeth Receives Positive Opinion from European Regulators for its 13-valent Pneumococcal Candidate Vaccine for Infants and Young Children
24 Sep 2009 Vical Presents Positive Preclinical Results with Vaxfectin(R)-Formulated, Peptide-based Cancer Vaccine
24 Sep 2009 Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV
22 Sep 2009 New and interesting PROSTVAC™ data indicate broad therapeutic use in metastatic prostate cancer
22 Sep 2009 Oxford BioMedica Presents Interim Results From Phase III TRIST Study of TroVax® In Renal Cancer
22 Sep 2009 Simcere Pharmaceutical Group Invested Company Obtains Production License for H1N1 Flu Vaccine
16 Sep 2009 STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
16 Sep 2009 FDA Approves Vaccines for 2009 H1N1 Influenza Virus
14 Sep 2009 Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine
14 Sep 2009 Variation Biotechnologies Flu Vaccine Provides Robust Immune Response, Broad Protection against H1N1 Influenza Strain
14 Sep 2009 Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top